国: オーストラリア
言語: 英語
ソース: Department of Health (Therapeutic Goods Administration)
finasteride, Quantity: 1 mg
Accord Healthcare Pty Ltd
Tablet, film coated
Excipient Ingredients: pregelatinised maize starch; sodium starch glycollate type A; magnesium stearate; lauroyl macrogolglycerides; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red
Oral
28 tablets
(S4) Prescription Only Medicine
FINASTERIDE ACCORD 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. FINASTERIDE ACCORD 1 is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.
Visual Identification: Reddish brown, 7 mm, round, biconvex, film-coated tablet, marked 'F1' on one side and plain on the other.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius
Registered
2020-05-04